erf3 as anti gfp clonetech (TaKaRa)
Structured Review
Erf3 As Anti Gfp Clonetech, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 419 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gfp+clonetech/Living+Colors+Full-Length+GFP+Polyclonal+Antibody/pm31597105-369-136-138
Average 96 stars, based on 419 article reviews
Images
Related Articles
Transgenic Assay:Article Title: Control of retrograde signalling by protein import and cytosolic folding stress. Article Snippet: Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).. All other antibodies were obtained from commercial suppliers: GFP: Co-Immunoprecipitation Assay:Article Title: Control of retrograde signalling by protein import and cytosolic folding stress. Article Snippet: Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).. All other antibodies were obtained from commercial suppliers: GFP: Control:Article Title: Control of retrograde signalling by protein import and cytosolic folding stress. Article Snippet: Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).. All other antibodies were obtained from commercial suppliers: GFP: Mass Spectrometry:Article Title: Control of retrograde signalling by protein import and cytosolic folding stress. Article Snippet: Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).. All other antibodies were obtained from commercial suppliers: GFP: Negative Control:Article Title: Control of retrograde signalling by protein import and cytosolic folding stress. Article Snippet: Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).. All other antibodies were obtained from commercial suppliers: GFP: Immunoprecipitation:Article Title: Control of retrograde signalling by protein import and cytosolic folding stress. Article Snippet: Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).. All other antibodies were obtained from commercial suppliers: GFP: Western Blot:Article Title: Control of retrograde signalling by protein import and cytosolic folding stress. Article Snippet: Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).. All other antibodies were obtained from commercial suppliers: GFP: Positive Control:Article Title: Control of retrograde signalling by protein import and cytosolic folding stress. Article Snippet: Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).. All other antibodies were obtained from commercial suppliers: GFP: Expressing:Article Title: Control of retrograde signalling by protein import and cytosolic folding stress. Article Snippet: Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).. All other antibodies were obtained from commercial suppliers: GFP: Mutagenesis:Article Title: Control of retrograde signalling by protein import and cytosolic folding stress. Article Snippet: Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).. All other antibodies were obtained from commercial suppliers: GFP: Quantitative RT-PCR:Article Title: Control of retrograde signalling by protein import and cytosolic folding stress. Article Snippet: Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).. All other antibodies were obtained from commercial suppliers: GFP: Gene Expression:Article Title: Control of retrograde signalling by protein import and cytosolic folding stress. Article Snippet: Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).Antibodies against GluTR (dilution: 1:1000) and GBP (dilution: 1:5000) were previously described (cited in the manuscript and also listed below).. All other antibodies were obtained from commercial suppliers: GFP: |
